Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-13, Stock:JNJ, The news for the past five days is as follows:
2018-03-06: NEWS1: Dow Ends Roller Coaster Session Higher.NEWS2: Dow Ends Roller Coaster Session Higher.NEWS3: Market Close Report: NASDAQ Composite index closes at 7,372.01 up 41.31 points.NEWS4: Market Close Report: NASDAQ Composite index closes at 7,372.01 up 41.31 points.NEWS5: What To Expect From Johnson & Johnson In 2018.NEWS6: Johnson & Johnson to Participate in Barclays Global Healthcare Conference.NEWS7: Johnson & Johnson’s Business Segments in 4Q17.NEWS8: Johnson & Johnson’s Revenues in 4Q17.NEWS9: Analyst: Insulet On Track For Profitability In 2018.NEWS10: Johnson & Johnson’s Valuation in February 2018.NEWS11: Stryker’s Mako Robot Sales Momentum Continues to Fuel Growth.
2018-03-07: NEWS1: SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Johnson & Johnson (NYSE: JNJ) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit.NEWS2: U.S. judge says opioid settlement roadblocks may prompt trials.NEWS3: Opioid Judge Allows Trial Prep as Settlement Talks Hit Snag.NEWS4: In Your 60s? 3 Stocks You Might Want to Buy.NEWS5: Boston Scientific Expands Its EMcision Business.NEWS6: EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Johnson & Johnson of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018.NEWS7: Analyzing Gilead Sciences’ Other Products in 4Q17.NEWS8: Johnson & Johnson’s Consumer Segment in 4Q17.NEWS9: How BMY’s Baraclude and Sustiva Franchise Performed.NEWS10: Will Recent Trade War Talk Affect the Health Care Sector in March?.NEWS11: SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018.NEWS12: Shire plc (SHPG) Ex-Dividend Date Scheduled for March 08, 2018.NEWS13: Shire plc (SHPG) Ex-Dividend Date Scheduled for March 08, 2018.NEWS14: Why Gilead Sciences’ Harvoni Lost Market Share in 4Q17.NEWS15: Johnson & Johnson’s Medical Devices Segment in 4Q17.NEWS16: How Bristol-Myers Squibb’s Sprycel and Empliciti Performed in 4Q17.NEWS17: Gilead Sciences’ HCV Products: Lower Revenues in 4Q17.NEWS18: Johnson & Johnson’s Pharmaceutical Segment in 4Q17.NEWS19: Do We Need to Rethink the Meaning of Design Thinking?.NEWS20: 3 Top Biotech Stocks to Buy in March.NEWS21: 3 Top Biotech Stocks to Buy in March.NEWS22: 3 Top Biotech Stocks to Buy in March.
2018-03-08: NEWS1: [$$] J&J Says Discounts Cut the Prices for Its Drugs, Though Revenue Rose.NEWS2: Stocks End Higher After Tariff Plan.NEWS3: Stocks End Higher After Tariff Plan.NEWS4: NASDAQ Composite Index closes up 24.64 points for the week, rising for the 5th straight day.NEWS5: NASDAQ Composite Index closes up 24.64 points for the week, rising for the 5th straight day.NEWS6: Judge's Order Sets 1,200 Xarelto Product Liability Lawsuits for Separate Jury Trials.NEWS7: JNJ EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018.NEWS8: Vanguard Value ETF Experiences Big Inflow.NEWS9: Vanguard Value ETF Experiences Big Inflow.NEWS10: The company that’s trying to change archaic methods within health care.NEWS11: Analyst Recommendations for Johnson & Johnson in February 2018.NEWS12: Analysts’ Recommendations for Gilead Sciences in March.NEWS13: Analysts’ Estimates for Johnson & Johnson after 4Q17.NEWS14: 3 Dividend Stocks Perfect for Retirees.NEWS15: 3 Dividend Stocks Perfect for Retirees.NEWS16: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS17: Changes in Johnson & Johnson’s Profit Margins in 4Q17.NEWS18: 3 Dividend Stocks Perfect for Retirees.
2018-03-09: NEWS1: FDA Approves Arm Indication for Medtronic’s Guardian Sensor 3.NEWS2: Medtronic Strengthens Diabetes Business with MiniMed Infusion Set.NEWS3: An Updated Technical Strategy on Johnson & Johnson.NEWS4: Is Big Pharma Using Corporate Tax Savings to Lower Drug Costs?.NEWS5: Is Big Pharma Using Corporate Tax Savings to Lower Drug Costs?.NEWS6: Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails.NEWS7: Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails.NEWS8: Stocks to Watch: Qualcomm, Netflix, Tesla, Chesapeake, Wynn, J&J, GM, Mattel, Big Lots, Finisar.NEWS9: Today’s Research Reports on Stocks to Watch: Johnson & Johnson and InVivo Therapeutics.NEWS10: [$$] Johnson & Johnson Says Discounts Cut the Prices for Its Drugs, Though Revenue Rose.
2018-03-12: NEWS1: Genomic Health Hits its Inflection Point.NEWS2: Genomic Health Hits its Inflection Point.NEWS3: Genomic Health Hits its Inflection Point.NEWS4: The 1 Big Risk That Every Drugmaker Fears.NEWS5: The 1 Big Risk That Every Drugmaker Fears.NEWS6: The 1 Big Risk That Every Drugmaker Fears.

Answer: Rise